Macrophage polarization induced by neuropeptide methionine enkephalin (MENK) promotes tumoricidal responses

Cancer Immunology, Immunotherapy

Volumn 61, Issue 10, 2012, Pages 1755-1768

  Chen, Wenna ^a,b   Liu, Jinling ^b   Meng, Jingjuan ^a   Lu, Changlong ^a   Li, Ximing ^a   Wang, Enhua ^a   Shan, Fengping ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b LIAONING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Macrophage; Methionine enkephalin; Polarization; Tumor Immunity

Indexed keywords

ARGINASE 1; CD206 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P40; LYMPHOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE COFACTOR PROTEIN; MESSENGER RNA; METENKEPHALIN; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMA; SPLEEN CELL; UPREGULATION;

ANIMALS; ARGINASE; CELL LINE, TUMOR; CELL POLARITY; CYTOKINES; DOWN-REGULATION; ENKEPHALIN, METHIONINE; HISTOCOMPATIBILITY ANTIGENS CLASS II; LECTINS, C-TYPE; MACROPHAGES; MALE; MANNOSE-BINDING LECTINS; MICE; MICE, INBRED C57BL; NEOPLASMS; NITRIC OXIDE SYNTHASE TYPE II; REACTIVE OXYGEN SPECIES; RECEPTORS, CELL SURFACE; RECEPTORS, IGG; UP-REGULATION;

EID: 84867580439     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-012-1240-6     Document Type: Article

References (37)

1. Sharp BM (2006) Multiple opioid receptors on immune cells modulate intracellular signaling. Brain Behav Immun 20:9-14
2. Donahue RN, McLaughlin PJ, Zagon IS (2009) Cell proliferation of human ovarian cancer is regulated by the opioid growth factoropioid growth factor receptor axis. Am J Physiol Regulatory Integrative Comp Physiol 296:R1716-R1725
3. Zagon IS, Donahue RN, McLaughlin PJ (2009) opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers. Am J Physiol Regulatory Integrative Comp Physiol 297:R1154-R1161
4. Piva M, Moreno JI, Jenkins FS, Smith JK, Thomas JL, Montgomery C, Wilson CB et al (2005) In vitro modulation of cytokine expression by enkephalin-derived peptide. Neuroimmuno-modulation 12:339-347
5. Zagon IS, Verderame MF, McLaughlin PJ (2002) The biology of the opioid growth factor receptor (OGFr). Brain Res Rev 38:351-376
6. Hatzoglou A, Kampa M, Castanas E (2005) Opioid-somatostatin interactions in regulating cancer cell growth. Frontiers in Bioscience 10:244-256
7. McLaughlin PJ, Stack BC, Braine KM, Ruda JD, Zagon IS (2004) Opioid growth factor (OGF) inhibition of a human squamous cell carcinoma of the head and neck in nude mice: dependency on the route of administration. Int J Oncol 24:227-232
8. Zagon IS, Jaglowski JR, Verderame MF, Smith JP, Leure-duPree AE, McLaughlin PJ (2005) Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma. Cancer Chemother Pharmacol 56:510-520
9. Naito M (2008) Macrophage differentiation and function in health and disease. Pathol Int 58:143-155
10. Mantovani A, Sica A, Locati M (2005) Macrophage polarization comes of age. Immunity 23:344-346
11. Gordon S (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27:451-483
12. Fengping S, Yanjie X, Ning W, Jingjuan M, Changlong L, Yiming M et al (2011) Functional modulation of the pathway between dendritic cells (DCs) and CD4?T cells by the neuropeptide: methionine enkephalin (MENK). Peptides 32:929-937
13. Quidville V, Segond N, Pidoux E, Cohen R, Jullienne A, Lausson S (2004) Tumor growth inhibition by indomethacin in a mouse model of human medullary thyroid cancer: implication of cyclooxygenases and 15-hydroxyprostaglandin dehydrogenase. Endocrinology 145:2561-2571
14. El-Gazzar A, Perco P, Eckelhart E, Anees M, Sexl V, Mayer B et al (2010) Natural immunity enhances the activity of a DR5 agonistic antibody and carboplatin in the treatment of ovarian cancer. Mol Cancer Ther 9:1007-1018
15. Umemura N, Saio M, Suwa T, Kitoh Y, Juncheng B, Nonaka K et al (2008) Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics. J Leukocyte Biology 83:1136-1144
16. Kang L, Wei X, Qiang G, Zhenggang J, Ping W, Yan Y et al (2009) Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis. Circ Res 105:353-364
17. Mittal R, Sukumaran SK, Selvaraj SK, Wooster DG, Babu MM, Schreiber AD et al (2010) Fcc receptor I alpha chain (CD64) expression in macrophages is critical for the onset of meningitis by Escherichia coli K1. PLoS Pathog 6:e1001203
18. Wei W, Jing W, Sheng-fu D (2010) Immunomodulatory activity of andrographolide on macrophage activation and specific antibody response. Acta Pharmacol Sin 31:191-201
19. Nicolas M, Derya U, Dan RL (2008) The differentiation of human TH-17 cells requires transforming growth factor-b and induction of the nuclear receptor RORct. Nat Immunol 9(6):641-649
20. Feng P, Yee KK, Rawson NE, Feldman LM, Feldman RS, Breslin PAS (2009) Immune cells of the human peripheral taste system: dominant dendritic cells and CD4 T-Cells. Brain Behav Immun 23:760-766
21. Marti'n L, Comalada M, Marti L, Closs EI, MacLeod CL, Ri'o RM et al (2006) Granulocyte-macrophage colony-stimulating factor increases L-Arginine transport through the induction of CAT2 in bone marrow-derived macrophages. Am J Physiol Cell Physiol 290:C1364-C1372
22. Sodhi A, Suresh A (1992) Production of reactive nitrogen intermediates by bone marrow-derived macrophages on treatment with cisplatin in vitro. Clin Exp Immunol 89:502-508
23. Stanojevića S, Vujićb V, Mitića K, Kustrimović N, Jovanović VK, Miletić T et al (2008) Methionine-enkephalin modulation of hydrogen peroxide (H2O2) release by rat peritoneal macrophages involves different types of opioid receptors. Neuropeptides 42:147-158
24. Vujićb V, Stanojevića S, Dimitrijević M (2004) Methionineenkephalin stimulates hydrogen peroxide and nitric oxide production in rat peritoneal macrophage: interaction of l, d and j opioid receptors. NeuroImmunoModulation 1:392-402
25. Vats D, Mukundan L, Odegaard JI, Lina Z, Smith KL, Morel CR et al (2006) Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab 4:13-24
26. Odegaard JI, Ricardo Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L et al (2007) Macrophage-specific PPAR controls alternative activation and improves insulin resistance. Nature 447:1116-1120
27. Kim K-R, Son E-W, Hee-Um S, Kim B-O, Rhee D-K, Pyo S (2003) Immune alterations in mice exposed to the herbicide simazine. J Toxicol Environ Health 66:1159-1173
28. Nathan C, Shiloh MU (2000) Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci USA 97:8841-8848
29. Zagon IS, Donahue RN, McLaughlin PJ (2009) opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers. Am J Physiol Regulatory Integrative Comp Physiol 297:R1154-R1161
30. Donahue RN, McLaughlin PJ, Zagon IS (2009) Cell proliferation of human ovarian cancer is regulated by the opioid growth factoropioid growth factor receptor axis. Am J Physiol Regulatory Integrative Comp Physiol 296:R1716-R1725
31. Smith JP, Bingaman SI, Mauger DT (2010) Opioid growth factor improves clinical benefit and survival in patients with advanced pancreatic Cancer. J Clinical Trials 2:37-48
32. McLaughlin PJ, Jaglowski JR (2005) Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of paclitaxel and opioid growth factor. Int J Oncol 26:809-816
33. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953-964
34. Al-Sarireh B, Eremin O (2000) Tumor-Associated macrophages (TAMS): disordered function, immune suppression and progressive tumor growth. J R Coll Surg Edinb 45:1-16
35. Sica A, Schioppa T, Mantovani A, Allavena P (2006) Tumorassociated macrophages are a distinct M2 polarised population promoting tumor progression: potential targets of anti-cancer therapy. Eur J Cancer 42:717-727
36. Mrass P, Takano H, Ng LG, Daxini S, Lasaro MO, Iparraguirre A et al (2006) Random migration precedes stable target cell interactions of tumor-infiltrating T cells. JEM 203:2749-2761
37. Leimgruber A, Berger C, Cortez-Retamozo V, Etzrodt M, Newton AP, Waterman P et al (2009) Behavior of endogenous tumorassociated macrophages assessed in vivo using a functionalized nanoparticlem. Neoplasia 11:459-468